Dexcom is proud to announce the first completely mobile continuous glucose monitoring system. With Bluetooth® technology that is now built in to the transmitter, your glucose data is sent wirelessly from the Dexcom G5 Mobile transmitter to your compatible smart device.
Continuous glucose monitoring (CGM) is an FDA-approved system that can help you reach your glycemic goals without an increased risk of hypoglycemia.1 While meters give a number for a single point in time, CGM provides dynamic glucose information by showing where glucose is, where it’s going, and how fast it’s getting there*.
Smart Device not included with the Dexcom G5 Mobile CGM System
For more flexibility, a Dexcom receiver comes with your system giving you another option to monitor your glucose.
With the Dexcom G5 Mobile CGM System, you’ll be alerted directly on your phone when you’re heading too high or too low. Alerts and alarm sounds can also be customized to appear as a text message, allowing for additional discretion and privacy.
1. The JDRF CGM Study Group. Diabetes Care, Vol. 32, Number 11, November 2009.
2. Dexcom G5 Mobile Continuous Glucose Monitoring System, User’s Guide, 2015.
3. Following requires the Dexcom Follow app
*The Dexcom G5 Mobile CGM System does not replace a blood glucose meter. Always use the values from your blood glucose meter for treatment decisions.
Lilly has been a global leader in diabetes care since 1923, when we introduced the world¹s first commercial insulin. Today we work to meet the diverse needs of people with diabetes through research and collaboration, a broad and growing product portfolio and a continued commitment to providing real solutions – from medicines to support programs and more – to make lives better. For more information, visit www.lillydiabetes.com.
Think about less worry over your child’s diabetes management – and more time spent watching them be a kid. With the OmniPod, YOU CAN. The OmniPod is an easy-to-use, two-part insulin pump designed to help make managing and living with diabetes easier for the child in your care:
The Small, Tubing-Free Pod
• Delivers insulin based on your child’s personalized settings.
• Adheres securely to most places you’d give an injection.
• Insertion is automatic and virtually pain-free – with no needles in sight.
• Waterproof* so there’s no need to disconnect for bathing or swimming.
The Handheld PDM
• Simple, intuitive sentences walk your child through every step.
• Can be stored in your child’s pocket, backpack or purse – no need to clip anything to your their clothing.
• Built-in blood glucose meter means one less things to carry.
• Insulin on board (IOB) is calculated based on correction and meal boluses.
Give your child a chance to feel what it’s like to wear the OmniPod. Learn more and order FREE Demo Kit here.
Meet an OmniPod Family:
Nancy and her Son, Ryan
Occupations: Real estate manager and student
They enjoy: Nancy likes seeing her son live life to the fullest and enjoys giving back to the diabetes community. Ryan enjoys not taking shots and just about every sport known to man.
Why they love the OmniPod: Nancy feels good knowing she’s doing the right thing for her son’s diabetes management. It gives them less stress, more control, freedom and normalcy.
*IPX8 (25 feet for up to 60 minutes). The PDM is not waterproof.
Sanofi strives to help people manage the complex challenge of diabetes by delivering innovative, integrated and personalized solutions. Driven by valuable insights that come from listening to and engaging with people living with diabetes, the Company is forming partnerships to offer diagnostics, therapies, services, and devices including blood glucose monitoring systems. Sanofi markets injectable, inhaled and oral medications for people with type 1 or type 2 diabetes.
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Sanofi is the holding company of a consolidated group of subsidiaries and operates in the United States as Sanofi US. For more information on Sanofi US, please visithttp://www.sanofi.us or call 1-800-981-2491.
The t:slim® Pump’s vivid color touch screen is your window to a streamlined, easy-to-use interface that places everything you want at your finger tip. Unlike other pumps requiring excessive scrolling and button pressing, the t:slim Pump is easy to learn and easy to use.
Currently the smallest insulin pump, the t:slim Insulin Delivery System is much slimmer than other 300-unit insulin pumps. With its slim, compact design, the t:slim pump can be slipped into a pocket or worn discreetly under clothing. With the footprint of a credit card and the look of a smart phone, its glass, chrome, and glossy exterior invite comparison with today's most popular handheld devices.
The t:slim Pump includes all of the smart features other pumps offer such as bolus calculator, insulin on board, and extended bolus, but they’re designed to be easy to find and easy to use.
The t:slim Pump uses a unique Micro-Delivery Technology designed with your safety in mind. It provides precision dosing and exceptional safety features not found on other pumps.
The t:slim Insulin Delivery System sports an integrated micro-USB port for easy, convenient charging and data transfer. It is the first pump powered by the latest rechargeable technology, eliminating the need for disposable batteries. The micro-USB port also provides unsurpassed speed when uploading pump data to its Mac and PC compatible Therapy Management Software.
Now you can spend more time enjoying life, and less time managing your pump.